Brief: Synaptogenix Provides Corporate Update And Outlines Potential Business Opportunities

TAO Synergies

07/03/2023 14:16

March 7 (Reuters) - Synaptogenix Inc  SNPX.O :
    * SYNAPTOGENIX PROVIDES CORPORATE UPDATE AND OUTLINES
POTENTIAL
BUSINESS OPPORTUNITIES
    * SYNAPTOGENIX INC - MAINTAINS STRONG FINANCIAL POSITION
WITH
APPROXIMATELY $37.5 MILLION IN CASH AS OF DECEMBER 31, 2022
    * SYNAPTOGENIX-ENCOURAGING SECONDARY ENDPOINT RESULTS FROM
NIH-SPONSORED PHASE 2 CLINICAL TRIAL OF BRYOSTATIN-1 IN ADVANCED
ALZHEIMER'S DISEASE PATIENTS
    * SYNAPTOGENIX INC - EXPLORING OPPORTUNITIES WHICH MAY
INCLUDE
ACQUIRING RIGHTS TO NEW ASSETS; CONTINUING COLLABORATIVE
RESEARCH WITH STRATEGIC PARTNERS

Source text for Eikon:  ID:nPnbpkVwRa 
Further company coverage:  SNPX.O 

 ((Reuters.Briefs@thomsonreuters.com;))